Examkin

Question

Difficulty: Very hardEndocrinology and Metabolism

A 5252-year-old male with resistant hypertension and unprovoked hypokalemia (serum K+K^+ 2.9 mEq/L2.9 \text{ mEq/L}) is evaluated for suspected primary hyperaldosteronism. His current daily medication regimen includes maximal doses of amlodipine, perindopril, and chlorthalidone. The clinical team is evaluating him for potential curative surgical intervention. Arrange the following steps in the correct chronological sequence for the definitive diagnostic and pre-operative workup of this condition.

  1. 1Discontinue perindopril and chlorthalidone, transitioning to non-interfering antihypertensive agents (e.g., doxazosin, verapamil).
  2. 2Measure the morning ambulatory plasma aldosterone concentration to plasma renin activity (PAC/PRA) ratio.
  3. 3Perform an intravenous saline infusion test to assess for aldosterone suppression.
  4. 4Obtain a high-resolution computed tomography (CT) scan of the adrenal glands.
  5. 5Perform bilateral adrenal venous sampling (AVS) with cosyntropin stimulation.

Answer

The correct diagnostic algorithm sequence is: 1) Medication washout, 2) PAC/PRA screening ratio, 3) Confirmatory saline infusion test, 4) Adrenal CT scan, 5) Adrenal venous sampling.
The diagnosis of primary hyperaldosteronism requires a strict, sequential algorithmic approach to avoid misdiagnosis and inappropriate surgery. First, interfering medications must be removed to ensure an accurate baseline. Next, the PAC/PRA ratio is used as a highly sensitive screen. If positive, a confirmatory suppression test (e.g., saline infusion) is required because the screening test lacks specificity. Once biochemically confirmed, anatomic localization with an adrenal CT is performed. Finally, because the patient is over 3535 years of age, anatomical imaging must be followed by functional localization using bilateral adrenal venous sampling to differentiate a unilateral aldosterone-producing adenoma from bilateral hyperplasia.

Step-by-Step Solution

1
Address interfering factors (Medication Washout).
Discontinuation of ACE inhibitors and diuretics, switching to alpha-blockers or non-dihydropyridine calcium channel blockers.
These medications independently alter renin and aldosterone secretion, which would invalidate subsequent biochemical screening.
2
Perform the initial biochemical screen (PAC/PRA Ratio).
Measurement of aldosterone and renin to calculate the ratio.
A ratio >20>20 with an aldosterone level >15 ng/dL>15 \text{ ng/dL} indicates probable autonomous aldosterone production.
3
Confirm autonomous hypersecretion (Confirmatory Test).
Administration of a saline infusion or oral sodium load.
Demonstrates that the aldosterone production cannot be suppressed by volume expansion, distinguishing true primary hyperaldosteronism from false-positives.
4
Perform initial anatomic localization (Adrenal CT).
High-resolution cross-sectional imaging of the adrenal glands.
Evaluates for large masses, bilateral hyperplasia, or potential adrenocortical carcinoma to guide the next invasive step.
5
Perform functional lateralization (Adrenal Venous Sampling).
Catheterization of both adrenal veins to measure aldosterone/cortisol ratios.
Essential in patients >35>35 years to ensure a visualized nodule is actually the source of hormone overproduction (avoiding inappropriate surgery for a non-functioning incidentaloma).

Key Concept

The precise, stepwise diagnostic algorithm for primary hyperaldosteronism (Conn syndrome).
Estimated Time:2m 0s
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic